In November 2022, revisions to the United States Pharmacopeia’s (USP) General Chapter <797>, a standard for sterile pharmaceutical compounding – defined as the process of “combining, admixing, diluting, pooling, reconstituting, repackaging, or otherwise altering a drug product or bulk drug substance to create a sterile medication” – were published. USP <797> plays a major role
Advocacy and collaboration lead to major patient safety benefits on sterile pharmaceutical compounding: a review of USP’s revisions to Chapter <797> originally appeared in KevinMD.com.
